Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Feb 12, 2009


Gentel Biosciences last week announced the promotion of G Randall Durnell to executive vice president and COO, and the hiring of Dan Clutter as vice president of commercial development.

Durnell joined Gentel a year ago and had been VP of commercial operations. In his new position, he will be responsible for all aspects of Gentel’s commercial operations including manufacturing and corporate development.

Clutter, who will report to Durnell, will be responsible for sales, marketing, and product commercialization. Clutter has held sales, marketing, and business development positions at PerkinElmer, Invitrogen, Roche, Celera, PanVera, Asterand, and NimbleGen.

Microarray firm Aushon BioSystems this week appointed Joseph Blanchard as COO.

Blanchard has more than 20 years of leadership experience in life sciences, and had been at Decision Biomarkers where he was senior vice president of business development and strategy.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.